These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Neurologic manifestations of essential thrombocythemia. Ann Intern Med; 1984 Feb 21; 100(2):316-7. PubMed ID: 6691684 [No Abstract] [Full Text] [Related]
46. Pegylated interferon therapy for patients with Philadelphia chromosome-negative myeloproliferative disorders. Quintás-Cardama A, Kantarjian HM, Giles F, Verstovsek S. Semin Thromb Hemost; 2006 Jun 21; 32(4 Pt 2):409-16. PubMed ID: 16810616 [Abstract] [Full Text] [Related]
47. Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema. Ito E, Muro Y, Shibata A, Sugiura K, Akiyama M. Dermatol Online J; 2014 Aug 17; 20(8):. PubMed ID: 25148281 [Abstract] [Full Text] [Related]
52. [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon]. Gotić M, Cvetković M, Bozanović T, Cemerikić V. Srp Arh Celok Lek; 2001 Sep 30; 129(11-12):304-8. PubMed ID: 11928616 [Abstract] [Full Text] [Related]
57. Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia. Alvarado Y, Cortes J, Verstovsek S, Thomas D, Faderl S, Estrov Z, Kantarjian H, Giles FJ. Cancer Chemother Pharmacol; 2003 Jan 30; 51(1):81-6. PubMed ID: 12497210 [Abstract] [Full Text] [Related]
59. Thrombocytosis associated with a myeloproliferative disorder in a dog. Degen MA, Feldman BF, Turrel JM, Goding B, Kitchell B, Mandell CP. J Am Vet Med Assoc; 1989 May 15; 194(10):1457-9. PubMed ID: 2722642 [Abstract] [Full Text] [Related]
60. Childhood essential thrombocytosis. Papageorgiou T, Theodoridou A, Kourti M, Nikolaidou S, Athanassiadou F, Kaloutsi V. Pediatr Blood Cancer; 2006 Dec 15; 47(7):970-1. PubMed ID: 16628554 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]